8247 Share Price Performance
HK$0.95
0.18 (23.38%)
Price HK$0.95
Share PriceHK$0.95
Biosino Bio-Technology and Science Incorporation's (HKG:8247) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Aug 07
Biosino Bio-Technology and Science Incorporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
8247 Community Narratives
There are no narratives available yet.
Biosino Bio-Technology and Science Incorporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.33
- Gross Margin
- 38.77%
- Net Profit Margin
- -21.03%
- Debt/Equity Ratio
- 88.2%
Biosino Bio-Technology and Science Incorporation Competitors
Snowflake Analysis
About 8247
- Founded
- 1988
- Employees
- 471
- CEO
- WebsiteView website
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the People’s Republic of China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.3%
- 1 Year: 24.1%
- Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. As for the past 12 months, the market is up 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›